Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
9,906.00
7,789.00
7,738.00
8,660.00
8,383.00
8,894.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
9,906.00
7,789.00
7,738.00
8,660.00
8,383.00
8,894.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
2,749.00
2,515.00
2,378.00
2,477.00
2,404.00
2,370.00
Operating Expenses
1.00
0.00
0.00
0.00
0.00
0.00
General and Administration Expenses
3,892.00
3,562.00
3,223.00
3,326.00
3,775.00
4,538.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
9,651.00
8,247.00
7,933.00
8,518.00
8,396.00
9,649.00
Operating Profit (PBDIT) excl Other Income
255.00
-457.00
-195.00
141.00
-13.00
-754.00
Other Income
2.00
467.00
405.00
61.00
296.00
250.00
Operating Profit (PBDIT)
628.00
372.00
554.00
566.00
753.00
-19.00
Interest
1.00
0.00
0.00
0.00
0.00
0.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
370.00
363.00
345.00
363.00
470.00
484.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
256.00
7.00
158.00
211.00
284.00
-703.00
Provision for Tax
29.00
-56.00
49.00
73.00
46.00
-101.00
Profit After Tax
227.00
64.00
108.00
138.00
238.00
-601.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
6.55
1.86
3.14
3.98
6.87
-17.34
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 27.18% vs 0.66% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 155.82% vs -134.15% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 114.85% vs 66.10% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 252.60% vs -40.86% in Mar 2025
Compare Profit and Loss Results of Wakamoto Pharmaceutical Co., Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(JPY)
Change(%)
No of Months
12
12
Operating Income
9,906.00
33,090.00
-23,184.00
-70.06%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
9,906.00
33,090.00
-23,184.00
-70.06%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
2,749.00
0.00
2,749.00
0%
Operating Expenses
1.00
225.00
-224.00
-99.56%
General and Administration Expenses
3,892.00
6,083.00
-2,191.00
-36.02%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
9,651.00
32,910.00
-23,259.00
-70.67%
Operating Profit (PBDIT) excl Other Income
255.00
180.00
75.00
41.67%
Other Income
2.00
427.00
-425.00
-99.53%
Operating Profit (PBDIT)
628.00
2,166.00
-1,538.00
-71.01%
Interest
1.00
225.00
-224.00
-99.56%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
370.00
1,559.00
-1,189.00
-76.27%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
256.00
221.00
35.00
15.84%
Provision for Tax
29.00
23.00
6.00
26.09%
Profit After Tax
227.00
198.00
29.00
14.65%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.5468
54.7909
-48.24
-88.05%
Profit And Loss - Net Sales
Net Sales 9,906.84 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 27.18% vs 0.66% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 255.54 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 155.82% vs -134.15% in Mar 2025
Profit And Loss - Interest
Interest 1.90 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 114.85% vs 66.10% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 227.22 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 252.60% vs -40.86% in Mar 2025






